中华传染病杂志
中華傳染病雜誌
중화전염병잡지
CHINESE JOURNAL OF INFECTIOUS DISEASES
2014年
1期
18-21
,共4页
李永成%高志刚%张颖%张之伦%曲江文%丁亚兴%田宏%陈德荣%刘明珠
李永成%高誌剛%張穎%張之倫%麯江文%丁亞興%田宏%陳德榮%劉明珠
리영성%고지강%장영%장지륜%곡강문%정아흥%전굉%진덕영%류명주
麻疹疫苗%接种%母亲%婴儿%抗体,病毒%免疫,主动
痳疹疫苗%接種%母親%嬰兒%抗體,病毒%免疫,主動
마진역묘%접충%모친%영인%항체,병독%면역,주동
Measles vaccine%Vaccination%Mothers%Infant%Antibodies,viral%Immunity,active
目的 评价母亲接种麻疹疫苗后对婴儿首针麻疹疫苗免疫成功率的影响,了解孕妇和婴儿的麻疹抗体水平及其关系.方法 按照近10年内母亲是否接种含麻疹成分疫苗选择研究对象,追踪监测孕妇分娩前、新生儿出生时、婴儿8月龄免疫前和接种疫苗后1个月的麻疹IgG抗体水平,采用ELISA法检测.抗体效价>200 mIU/mL为阳性,>1 000 mIU/mL为保护性抗体水平阳性.采用t检验和卡方检验.结果 共调查107对研究对象,其中接种疫苗组41对,未接种疫苗组66对.母亲接种疫苗组新生儿麻疹保护性抗体阳性21名,占51.2%,未接种疫苗组阳性19名,占28.8%(x2 =5.436,P=0.020);新生儿麻疹保护性抗体几何平均效价(GMC)分别为735.3和566.7 mIU/mL(t'=2.064,P=0.043);两组分别检测36名和60名免疫前后的婴儿,母亲接种疫苗组首针免疫成功率为91.7%,未接种疫苗组为90.0%(校正x2=0.075,P=0.785);免疫后1个月麻疹保护性抗体GMC分别为1 055.6和926.0 mIU/mL(t=1.648,P=0.103).结论 母亲接种含麻疹成分疫苗后不影响8月龄婴儿首针麻疹疫苗的免疫成功率和抗体效价,能提高孕妇和新生儿麻疹保护性抗体阳性率,抗体效价也显著增高.
目的 評價母親接種痳疹疫苗後對嬰兒首針痳疹疫苗免疫成功率的影響,瞭解孕婦和嬰兒的痳疹抗體水平及其關繫.方法 按照近10年內母親是否接種含痳疹成分疫苗選擇研究對象,追蹤鑑測孕婦分娩前、新生兒齣生時、嬰兒8月齡免疫前和接種疫苗後1箇月的痳疹IgG抗體水平,採用ELISA法檢測.抗體效價>200 mIU/mL為暘性,>1 000 mIU/mL為保護性抗體水平暘性.採用t檢驗和卡方檢驗.結果 共調查107對研究對象,其中接種疫苗組41對,未接種疫苗組66對.母親接種疫苗組新生兒痳疹保護性抗體暘性21名,佔51.2%,未接種疫苗組暘性19名,佔28.8%(x2 =5.436,P=0.020);新生兒痳疹保護性抗體幾何平均效價(GMC)分彆為735.3和566.7 mIU/mL(t'=2.064,P=0.043);兩組分彆檢測36名和60名免疫前後的嬰兒,母親接種疫苗組首針免疫成功率為91.7%,未接種疫苗組為90.0%(校正x2=0.075,P=0.785);免疫後1箇月痳疹保護性抗體GMC分彆為1 055.6和926.0 mIU/mL(t=1.648,P=0.103).結論 母親接種含痳疹成分疫苗後不影響8月齡嬰兒首針痳疹疫苗的免疫成功率和抗體效價,能提高孕婦和新生兒痳疹保護性抗體暘性率,抗體效價也顯著增高.
목적 평개모친접충마진역묘후대영인수침마진역묘면역성공솔적영향,료해잉부화영인적마진항체수평급기관계.방법 안조근10년내모친시부접충함마진성분역묘선택연구대상,추종감측잉부분면전、신생인출생시、영인8월령면역전화접충역묘후1개월적마진IgG항체수평,채용ELISA법검측.항체효개>200 mIU/mL위양성,>1 000 mIU/mL위보호성항체수평양성.채용t검험화잡방검험.결과 공조사107대연구대상,기중접충역묘조41대,미접충역묘조66대.모친접충역묘조신생인마진보호성항체양성21명,점51.2%,미접충역묘조양성19명,점28.8%(x2 =5.436,P=0.020);신생인마진보호성항체궤하평균효개(GMC)분별위735.3화566.7 mIU/mL(t'=2.064,P=0.043);량조분별검측36명화60명면역전후적영인,모친접충역묘조수침면역성공솔위91.7%,미접충역묘조위90.0%(교정x2=0.075,P=0.785);면역후1개월마진보호성항체GMC분별위1 055.6화926.0 mIU/mL(t=1.648,P=0.103).결론 모친접충함마진성분역묘후불영향8월령영인수침마진역묘적면역성공솔화항체효개,능제고잉부화신생인마진보호성항체양성솔,항체효개야현저증고.
Objective To evaluate the influence of mothers' measles vaccination on the success rate of infants' first-dose measles vaccination and to access the relationship between mothers' anti-measles antibody levels and their infants'.Methods The recruited pregnant women were divided into two groups according to their measles vaccination history in recent 10 years,and their anti measles IgG antibody levels were detected by enzyme-linked immunosorbent assay (ELISA).The anti-measles antibody levels of the corresponding infants were detected by ELISA at birth,8-months after birth (before measles vaccination)and one month after measles vaccination.The concentration of anti-measles IgG antibody >200 mIU/mL was considered as seropositive,and 1 000 mIU/mL was considered as protective level.Chi square test and t test were used for statistical analysis.Results A total of 107 pairs of objects were included in this study,with 41 pairs in vaccinated group and 66 pairs in non-vaccinated group.The rates of newborn infants whose anti-measles antibody reached protective level in vaccinated group and non-vaccinated group were 51.2% and 28.8%,respectively (x2 =5.436,P=0.020).And the geometric mean concentrations (GMC) of anti-measles antibody in the two groups were 735.3 mIU/mL and 566.7 mIU/mL,respectively (t'=2.064,P=0.043).The success rates of infants' first dose measles vaccination in the two groups were 91.7% and 90.0%,respectively (x2 =0.075,P=0.785).One month after vaccination,the GMC were 1 055.6 mIU/mL and 926.0 mIU/mL,respectively (t= 1.648,P=0.103).Conclusions Using measles-containing vaccine in reproductive women dose not influence the success rate of infants' first-dose measles vaccination 8-months after birth and does not influence the concentration of anti-measles antibody produced one month after vaccination.However,mothers' measles vaccination can increase the protective antibody levels in their infants.